Amgen and Sanofi to Cut Cholesterol Molecules' Prices - Bidness ETC

Bidness ETC

Amgen and Sanofi to Cut Cholesterol Molecules' Prices Bidness ETC On Tuesday,the Journal of the American Medical Association in a study opined that Amgen, Inc. (NASDAQ:AMGN), Sanofi SA, and Regeneron's cholesterol-lowering molecules have to cut prices to more than two-third in order get momentum in the revenue ... Price of new cholesterol drugs challenge health care systemDaily Record JAMA: PCSK9s should cost $4536, but don'tBioPharma Dive Study Finds PCSK9s Are Not Cost-Effective, and Drugmakers Aren't HappyAJMC.com Managed Markets Network UPI.com -Pharmacy Today, American Pharmacists Association, pharmacist.com -Doctors Lounge -The Pharma Letter (registration) all 9 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNHfZlZjsP_qrdL02jS0RFVRNybFKg&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779183897328&ei=_qG0V-CtEMal3gGizIHYBQ&url=http://www.bidnessetc.com/72349-amgen-sanofi-cut-cholesterol-molecules-prices/
via IFTTT